Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?
INTRODUCTION:Mycobacterium ulcerans (M. ulcerans) is a necrotizing skin infection endemic to the Bellarine Peninsula, Australia. Current treatment recommendations include 8 weeks of combination antibiotics, with adjuvant surgery if necessary. However, antibiotic toxicity often results in early treat...
Saved in:
Main Authors: | Raquel Cowan (Author), Eugene Athan (Author), N Deborah Friedman (Author), Andrew J Hughes (Author), Anthony McDonald (Author), Peter Callan (Author), Janet Fyfe (Author), Daniel P O'Brien (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes.
by: Daniel P O'Brien, et al.
Published: (2015) -
Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.
by: Daniel P O'Brien, et al.
Published: (2018) -
Clinical features and risk factors of oedematous Mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic area.
by: Daniel P O'Brien, et al.
Published: (2014) -
Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.
by: N Deborah Friedman, et al.
Published: (2013) -
Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.
by: Daniel P O'Brien, et al.
Published: (2012)